The rapid rise in diabetes in Nigeria is fueled by factors such as unhealthy diets, sedentary lifestyles, obesity, and an aging population. This surge has led to an increased incidence of complications like diabetic foot ulcers (DFUs), which are among the most serious complications of diabetes mellitus and a common cause of amputation in Nigeria.
In this context, the research conducted by Ifeoluwapo Jegede, a biochemistry graduate from the University of Medical Sciences, Ondo, is a timely contribution to combating one of the most devastating complications of the disease.
Her study identified that fluoroquinolones (ciprofloxacin and ofloxacin), gentamicin, and nitroimidazole are effective against Candida albicans and Streptococcus intermedius isolated from DFUs, despite the growing concern of antimicrobial resistance.
This finding provides evidence-based guidance for the selection of effective antibiotics in the treatment of DFUs, potentially reducing the risk of amputations and improving patient outcomes.
Furthermore, Jegede’s research underscores the importance of continuous surveillance of antimicrobial susceptibility patterns in Nigeria. By identifying effective antibiotics and highlighting resistance trends, her work contributes to the development of targeted treatment protocols, which are essential in combating the dual challenges of rising diabetes prevalence and antimicrobial resistance in the country. In summary, the increasing burden of diabetes in Nigeria necessitates effective management strategies for complications like DFUs. Research such as Jegede’s plays a pivotal role in informing clinical practices and public health policies, ultimately aiming to mitigate the impact of diabetes-related complications on the Nigerian population.
READ MORE FROM: NIGERIAN TRIBUNE
and then